New law strengthens punishment for assaulting health sector workers

New law strengthens punishment for assaulting health sector workers

July 27 2018 A new law will increase the possible sentencing of someone who commits common...

Home Office gives go ahead to allow cannabis-derived medicinal products on prescription

Home Office gives go ahead to allow cannabis-derived medicinal products on prescription

July 27 2018 Certain cannabis-derived products will be reclassified as Class 2 medicinal...

Review on prescribed medicines sets out scope and terms of reference

Review on prescribed medicines sets out scope and terms of reference

July 24 2018 A review of prescribed medicines looking at the evidence of dependence and...

AMs recommend that pharmacists have access to palliative care data in Wales

AMs recommend that pharmacists have access to palliative care data in Wales

July 18 2018 Community pharmacists should be among those health professionals who are alerted to...

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

July 18 2018 The Association of Pharmacy Technicians UK is questioning a survey on pharmacy...

  • New law strengthens punishment for assaulting health sector workers

    New law strengthens punishment for assaulting health sector workers

    Friday, 27 July 2018 16:08
  • Home Office gives go ahead to allow cannabis-derived medicinal products on prescription

    Home Office gives go ahead to allow cannabis-derived medicinal products on prescription

    Friday, 27 July 2018 15:58
  • Review on prescribed medicines sets out scope and terms of reference

    Review on prescribed medicines sets out scope and terms of reference

    Tuesday, 24 July 2018 12:30
  • AMs recommend that pharmacists have access to palliative care data in Wales

    AMs recommend that pharmacists have access to palliative care data in Wales

    Wednesday, 18 July 2018 17:41
  • APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    Wednesday, 18 July 2018 17:17

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a person taking pills imageFebruary 2 2018

Details of the review into prescribed medicines that may cause dependence or withdrawal have been set out.

Public Health Minister Steve Brine has commissioned Public Health England to review the evidence and report back in early 2019. It has been asked to look at:

  • prevalence and prescribing patterns;
  • the nature and likely causes of dependence or discontinuation syndrome among some people who take these medicines;
  • effective prevention and treatment of dependence and discontinuation syndrome for each drug category.

Drug classes specifically targeted will be benzodiazepines, Z-drugs, GABA-ergic medicines, opioid pain medications, antidepressants, as well as those that are prescribed to treat anxiety, insomnia, chronic non-cancer pain and depression. The review will look at the use of the medicines by adults, and community prescribing.

Not included in the review’s remit are:

  • cancer and terminal pain;
  • over-the-counter medicines;
  • prescribing in hospitals and prisons;
  • other medicines, such as anti-psychotics, stimulants, ‘smart drugs’, or anti-obesity drugs.

PHE will use a number of methods to gather evidence, including “analysing all prescription and some GP patient data to understand prevalence and detail of prescribing patterns, patients and conditions.”

Link:
PHE announcement     

Legal & Policy News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...